ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age [clear]
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level
Results 11 - 20 of 147
PD102854
Presenter(s): Anne C Reed, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This on demand webinar explores the special education process from referral to dismissal under the federal Individuals with Disabilities Education Act (IDEA) as it relates to students with speech-language disorders. The speaker discusses the role of the SLP, response to intervention (RTI) strategies, and the development of IEPs with specific goals to meet the individual needs of students. The webinar discusses principles and rules from the ASHA Code of Ethics that support ethical decision-making throughout the process.
Webinar product cover
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This on demand webinar will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
Product cover image
Presenter(s): Stacey L Pavelko, PhD, CCC-SLP, FNAP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: When providing services for elementary students with speech sound disorders, you might ask: Is pull-out the best service delivery model for this student? How can I collaborate with teachers to promote generalization? Would classroom-based services be appropriate? This on demand webinar will review models of co-teaching and apply them to specific students and situations, explore practical resources to enhance collaboration, and guide you through developing a plan to increase effective collaboration in your work environment.
Webinar product cover
Presenter(s): Rebecca Witmer, LCSW; Kaitlyn Mulray, MS, CCC-SLP; Melissa Ferrello, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: TMPRSS3 is a genetic variant associated with either progressive or congenital bilateral sensorineural hearing loss. Through case studies, this on demand webinar will address multidisciplinary management spanning from diagnosis of hearing loss to cochlear implantation. The presenters will share relevant education for professionals working with children with hearing loss.
Webinar product cover
Presenter(s): Dylan Chan, MD, PhD; Karen G Munoz, EdD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Early childhood is a critical period for auditory, language, and cognitive development, and early identification of permanent hearing loss provides the opportunity for children to receive appropriate and timely intervention and educational services. When children are identified late, they are at increased risk of permanent speech, language, and educational delays. This on demand webinar will discuss the prevalence of late-identified hearing loss in young children, opportunities to identify hearing problems, and stakeholder actions needed to support child development.
Presenter(s): Julie D Malone, MS, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session explores workload and identifies ways to educate SLPs and their employers on the topic to improve recruitment and retention in our field as well as SLPs' mental health and productivity, all of which translates to better services for students.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: This SIG 9 Perspectives course includes three articles from a forum on pediatric hearing health care disparities. The articles discuss barriers to follow-up in Early Hearing Detection and Intervention (EHDI) programs; systematic evaluation of family barriers to care; and the principles and implementation of trauma-informed care in pediatric hearing health care.
Presenter(s): Elizabeth Adams Costa, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Published research indicates that outcomes in children with hearing loss are generally lower than their hearing counterparts. Given the cascading effects auditory deprivation and language delays may cause in children, providing differential diagnoses can present a challenge. This course identifies commonly occurring comorbid presentations in children with hearing loss and describes the process of making differential diagnoses.
Presenter(s): A.U. Bankaitis, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medical professionals who use hearing aids can face challenges when they need to perform auscultation (listening to sounds from various organs, most often with a stethoscope) as part of their job. While the options may not seem straightforward, audiologists can play a key role in helping these medical professionals find an amplified stethoscope solution. This on demand webinar will discuss key considerations, potential options, and practical steps for helping medical professionals with hearing loss obtain the best solution.
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Ototoxic medications and chemical agents in the workplace can put individuals' hearing and vestibular health at risk for permanent injury. Proactive ototoxicity management (OtoM) strategies aim to minimize exposure, avoid onset of symptoms, provide ongoing monitoring, and manage auditory and vestibular changes as the clinical needs of the patient evolve. During a 2021 American Speech-Language-Hearing Association Special Interest Groups Open House, members of the International Ototoxicity Management Group discussed how best to integrate OtoM into routine clinical practice, what tools to use, and what special considerations need to be understood to best support patients and their families. Here, we have summarized their viewpoints to encourage widespread adoption of improved OtoM services for at-risk individuals. The field of audiology needs to move to a place where we better understand the full extent of ototoxicity and can agree on expanding minimum guidelines that can be implemented more universally to mitigate, detect, and manage the damage from ototoxic exposures. Only recently has our field seen a therapeutic drug that can protect against ototoxicity; however, the population served is restricted only to children receiving treatment for nonmetastatic carcinoma. This is hopefully just the beginning of future therapeutic interventions to come, but, in the meantime, ototoxicity resulting from other medications in different patient populations and chemical agents persists.
<< 1 2 3 4 5 6 7 8 9 10 >>